Skip to main content
. 2024 Nov;45(11):1245–1252. doi: 10.15537/smj.2024.45.11.20240444

Table 1.

- Patients and disease characteristics (N=38).

Characteristics n (%)
Gender
Male 19 (50.0)
Female 19 (50.0)
Age at diagnosis, median (range) 4 (0-72)
Age group
Up to 4 months 20 (52.6)
4-12 months 14 (36.8)
Over 12 months 4 (10.5)
Diagnosis
Qatar 24 (63.1)
Elsewhere 14 (36.9)
Family history
Yes 10 (26.3)
No 28 (73.7)
Genetic analysis
Mutation in TSC1 1 (2.6)
Mutation in TSC2 33 (86.8)
Genetic studies negative 4 (10.5)
Presentation
Infantile spasms 14 (36.8)
Seizures (other than infantile spasms) 18 (47.3)
Developmental delay 5 (13.1)
Cardiac rhabdomyoma 8 (21.0)
Hypopigmented spots 5 (13.1)
Major criteria for TSC
Hypomelanotic nodules 29 (76.3)
Angiofibroma 20 (52.6)
Ungual fibroma 0 (0.0))
Shagreen patch 7 (18.4)
Retinal hamartoma 5 (13.1)
Cortical dysplasia 29 (76.3)
Subependymal nodules 37 (97.3)
SEGA 10 (26.3)
Cardiac rhabdomyoma 16 (42.1)
LAM 0 (0.0)
AML 22 (57.8)
Minor criteria for TSC
Confetti lesions 4 (10.5)
Dental enamel pits 2 (5.3)
Intra-oral fibroma 2 (5.3)
Retinal achromic patch 0 (0.0)
Multiple renal cysts 29 (76.3)
Non-renal hamartomas 4 (10.5)
Neuro-imaging features
Tubers 37 (97.3)
SEN 37 (97.3)
SEGA 10 (26.3)

Values are presented as numbers and percentages (%).

TSC: tuberous sclerosis complex, SEGA: subependymal giant cell astrocytoma, LAM: lymphangioleiomyomatosis, AML: angiomyolipoma, SEN: subependymal nodules